Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Treasury Shares: 2015-2024

Historic Treasury Shares for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $2.3 million.

  • Editas Medicine's Treasury Shares fell 74.32% to $652,267 in Q3 2025 from the same period last year, while for Sep 2025 it was $652,267, marking a year-over-year decrease of 74.32%. This contributed to the annual value of $2.3 million for FY2024, which is 10.41% up from last year.
  • As of FY2024, Editas Medicine's Treasury Shares stood at $2.3 million, which was up 10.41% from $2.1 million recorded in FY2023.
  • Editas Medicine's 5-year Treasury Shares high stood at $2.3 million for FY2024, and its period low was $507,450 during FY2020.
  • Its 3-year average for Treasury Shares is $2.0 million, with a median of $2.1 million in 2023.
  • In the last 5 years, Editas Medicine's Treasury Shares fell by 12.72% in 2020 and then surged by 138.43% in 2022.
  • Over the past 5 years, Editas Medicine's Treasury Shares (Yearly) stood at $507,450 in 2020, then rose by 23.90% to $628,732 in 2021, then soared by 138.43% to $1.5 million in 2022, then spiked by 40.56% to $2.1 million in 2023, then increased by 10.41% to $2.3 million in 2024.